2Lown B. Electrical reversion of cardiac arrhythmias [ J ]. Br Heart J,1967,29(4) :469. 被引量：1
3Madrid AH, Bueno MG, Rehollo JM ,et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fihrillation: a prospective and randomized study [ J ]. Circulation, 2002,106 ( 3 ) :331. 被引量：1
5Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ ESC guidelines for the management of patients with atrial fihrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Europeah Society of Cardiology Committee for practice Guideline and Policy Conferences[ J]. Eur Heart J,2001,22(20) :1852. 被引量：1
6Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med,2002,347(23) :1825. 被引量：1
2[1]Saxonhouse SJ,Curtis AB.Risks and benefits of rate control versus maintenance of sinus rhythm[J].Am J Cardiol,2003,91(6A):27D-32D. 被引量：1
3[2]Hagens VE,Ranchor AV,Van Sonderen.Effect of rate or rhythm control on quality of life in persistent atrial fibrillation.Results from the rate control versus electrical cardioversion(RACE)Study[J].J Am Coll Cardiol,2004,21,43(2):241-247. 被引量：1
4[3]Opolski G,Torbicki A,Kosior DA.Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation:the results of the polish how to treat chronic atrial fibrillation(HOT CAFE)Study[J].Chest,2004,126(2):476-486. 被引量：1
5[4]Olshansky B,Rosenfeld LE,Warner AL.The atrial fibrillation follow-up investigation of rhythm management(AFFIRM)study:approaches to control rate in atrial fibrillation[J].J Am Coll Cardiol,2004,43(7):1201-1208. 被引量：1
6[5]Kumana CR,Cheung BM,Cheung GT.Rhythm vs rate control of atrial fibrillation meta-analysed by number needed to treat[J].Br J Clin Pharmacol,2005,60(4):347-354. 被引量：1
7[6]Petersen P,Grind M,Adler.Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.SPORTIF Ⅱ:a dose-guiding,tolerability,and safety study[J].J Am Coll Cardiol,2003,41(9):1445-1451. 被引量：1
8[7]Halperin JL.Executive Steering Committee,Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation:Rationale,objectives,and design of a pair of clinical studies and baseline patient characteristics(SPORTIF Ⅲ and V)[J].Am Heart J,2003,146(3):431-438. 被引量：1
9[8]Boos CJ,More RS.Anticoagulation for non-valvular atrial aibrillation-towards a new beginning with ximelagatran[J].Curr Control Trials Cardiovasc Med,2004,5(1):3. 被引量：1
10[9]Peters RJ,Mehta SR,Fox KA.Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes:observations from the clopidogrel in unstable angina to prevent recurrent events(CURE)study[J].Circulation,2003,108(14):1682-1687. 被引量：1
2Je H G, Song H, Jung S H, et al. Impact of the Maze operation on the progression of mild functional tricuspid regurgitation[ J ]. J Thorac Cardiovasc Surg, 2008, 136 (5) : 1187 - 1192. 被引量：1
3Kim J B, Ju M H, Yun S C, et al. Mitral valve replacement with or without a concomitant Maze procedure in patients with atrial fibritlation[J]. Heart, 2010, 96(14): 1126 -1131. 被引量：1
4Leithauser B, Jung F, Park J W. Rheologieal and hemostasiological aspects of thrombus formation in the left atrial appendage in atrial fibrillation? A new strategy for prevention of cardioembolic stroke [J].Clin Hemorheol Microcirc, 2010, 45(2/4) : 311 -323. 被引量：1
5Salem D N, O' Gara P T, Madias C, et al. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Praetiee Guidelines ( 8th Edition)[J]. Chest, 2008, 133 (6 Suppl) : 593S-629S. 被引量：1
6Van-Wagoner D R. Recent insights into the pathophysiology of atrial fibrillation[J]. Semin Thorac Cardiovasc Surg, 2007, 19( 1 ) : 9 - 15. 被引量：1
7Kourliouros A, Savelieva I, Kiotsekoglou A, et al. Current concepts in the pathogenesis of atrial fibrillation[J]. Am Heart J, 2009, 157(2) : 243 - 252. 被引量：1
8Eckstein J, Verheule S, de-Groot N M, et al. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria [ J ]. Prog Biophys Mol Biol, 2008, 97(2/3): 435-451. 被引量：1
9Feigin V L, Lawes C M, Bennett D A, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies : a Systematic review[J]. Lancet Neurol, 2009, 8(4) : 355 -369. 被引量：1
10Heeringa J, Conway D S, van-der-Kuip D A, et al. A longitudinal poputation-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999 [ J ]. J Thromb Haemost, 2006, 4(9) : 1944 - 1949. 被引量：1
